Jianfu Zhao

1.2k total citations
43 papers, 942 citations indexed

About

Jianfu Zhao is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Jianfu Zhao has authored 43 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Biomedical Engineering. Recurrent topics in Jianfu Zhao's work include Nanoplatforms for cancer theranostics (10 papers), Selenium in Biological Systems (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jianfu Zhao is often cited by papers focused on Nanoplatforms for cancer theranostics (10 papers), Selenium in Biological Systems (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jianfu Zhao collaborates with scholars based in China, South Korea and Australia. Jianfu Zhao's co-authors include Tianfeng Chen, Delong Zeng, Ligeng Xu, Qi Chen, Ting Liu, Li-Zhen He, Ka‐Hing Wong, Meng Xu, Hailin Tang and Leung Chan and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and PLoS ONE.

In The Last Decade

Jianfu Zhao

42 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianfu Zhao China 18 355 252 183 157 152 43 942
Qianqian Yu China 13 299 0.8× 168 0.7× 179 1.0× 183 1.2× 153 1.0× 45 1.1k
Qianqian Yu China 21 552 1.6× 184 0.7× 98 0.5× 136 0.9× 144 0.9× 37 1.0k
Qinxin Zhao China 6 238 0.7× 201 0.8× 102 0.6× 113 0.7× 75 0.5× 16 647
Mahadeo Gorain India 20 493 1.4× 352 1.4× 233 1.3× 234 1.5× 163 1.1× 34 1.3k
Yi Ma China 16 370 1.0× 315 1.3× 137 0.7× 124 0.8× 40 0.3× 44 858
Cailian Wang China 19 390 1.1× 442 1.8× 206 1.1× 280 1.8× 54 0.4× 53 1.4k
Binhua Zou China 13 395 1.1× 294 1.2× 67 0.4× 121 0.8× 96 0.6× 23 927
Jacinta O. Pinho Portugal 14 359 1.0× 249 1.0× 83 0.5× 104 0.7× 38 0.3× 27 976
Davoud Jafari-Gharabaghlou Iran 17 355 1.0× 152 0.6× 82 0.4× 56 0.4× 58 0.4× 42 871
Naoki Nanashima Japan 18 295 0.8× 86 0.3× 109 0.6× 187 1.2× 68 0.4× 51 933

Countries citing papers authored by Jianfu Zhao

Since Specialization
Citations

This map shows the geographic impact of Jianfu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfu Zhao more than expected).

Fields of papers citing papers by Jianfu Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfu Zhao. The network helps show where Jianfu Zhao may publish in the future.

Co-authorship network of co-authors of Jianfu Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfu Zhao. A scholar is included among the top collaborators of Jianfu Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfu Zhao. Jianfu Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Guojun, Ke Li, Xinhai Zhu, et al.. (2025). Retinoic acid enhances γδ T cell cytotoxicity in nasopharyngeal carcinoma by reversing immune exhaustion. Cell Communication and Signaling. 23(1). 156–156.
3.
Zhao, Yang, et al.. (2025). The association between life’s essential 8 and gallstones: A cross-sectional study. Scientific Reports. 15(1). 4713–4713. 1 indexed citations
4.
Zhang, Zhongyang, Wei Huang, Jianfu Zhao, et al.. (2024). MoSe2-based magnetic nanosystem for clinical enrichment, retrieval and elimination of circulating tumor cells. Nano Today. 57. 102330–102330. 3 indexed citations
5.
Liu, Jun, Wenfu Wu, Siyu Zhao, et al.. (2023). Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection. European Journal of Medicinal Chemistry. 263. 115972–115972. 11 indexed citations
6.
Huang, Wei, Lizhen He, Shiqing Nie, et al.. (2023). Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment. Nano Today. 50. 101819–101819. 16 indexed citations
7.
Wang, Sheng, Maohua Huang, Minfeng Chen, et al.. (2023). Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells. Journal for ImmunoTherapy of Cancer. 11(6). e006381–e006381. 13 indexed citations
8.
Liu, Jun, Ying Shirley Meng, Xiaoyi Zhang, et al.. (2023). Design, synthesis and biological evaluation of novel 3-hydroxypyridin-4(1H)-ones based hybrids as Pseudomonas aeruginosa biofilm inhibitors. European Journal of Medicinal Chemistry. 259. 115665–115665. 17 indexed citations
9.
Feng, Bin, Yan Zhang, Ting Liu, et al.. (2023). Selenium speciation determines the angiogenesis effect through regulating selenoproteins to trigger ROS-mediated cell apoptosis and cell cycle arrest. Chinese Chemical Letters. 34(11). 108264–108264. 15 indexed citations
10.
Zhao, Siyu, Qiang Zhang, Jianfu Zhao, et al.. (2023). Novel Coumarin Derivatives Inhibit the Quorum Sensing System and Iron Homeostasis as Antibacterial Synergists against Pseudomonas aeruginosa. Journal of Medicinal Chemistry. 66(21). 14735–14754. 20 indexed citations
11.
Zhou, Zhigang, Jing Qin, Cailu Song, et al.. (2023). circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. Journal of Cancer. 14(13). 2574–2584. 40 indexed citations
12.
Zhang, Bei, Zhiyao Ren, Jianfu Zhao, et al.. (2023). Global analysis of HLA-A2 restricted MAGE-A3 tumor antigen epitopes and corresponding TCRs in non-small cell lung cancer. Theranostics. 13(13). 4449–4468. 10 indexed citations
13.
Li, Juanjuan, et al.. (2021). Designing DNA cage-based immuno-fluorescence strategy for rapid diagnosis of clinical cervical cancer tissues. Chinese Chemical Letters. 33(2). 788–792. 11 indexed citations
15.
Xiao, Wei, Jiajie Liang, Ying Zhang, et al.. (2021). CD8 cell counting in whole blood by a paper-based time-resolved fluorescence lateral flow immunoassay. Analytica Chimica Acta. 1179. 338820–338820. 14 indexed citations
16.
Ye, Ling, Jianfu Zhao, Yiming Wang, et al.. (2020). Brucea javanica oil emulsion suppresses tumor growth in human cervical cancer cells through inhibition of the E6 oncogene and induction of apoptosis. Translational Cancer Research. 9(2). 918–929. 12 indexed citations
17.
Liu, Feng, Hongjuan Hu, Jianfu Zhao, et al.. (2018). miR‑124‑3p acts as a potential marker and suppresses tumor growth in gastric cancer. Biomedical Reports. 9(2). 147–155. 33 indexed citations
18.
Zhao, Jianfu, Delong Zeng, Yuedan Liu, et al.. (2017). Selenadiazole derivatives antagonize hyperglycemia-induced drug resistance in breast cancer cells by activation of AMPK pathways. Metallomics. 9(5). 535–545. 9 indexed citations
19.
Wang, Liang, et al.. (2015). microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumor Biology. 36(5). 3911–3917. 23 indexed citations
20.
Zhao, Jianfu, et al.. (2001). [CT appearance and its diagnosis value in liver cancer after transcatheter oily chemoembolization combining with high intensity focused ultrasound therapy].. PubMed. 9 Suppl. 61–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026